AIM-HIGH falls shortNIH puts an early end to its trial of combination cholesterol therapy Letters: Discussing DabigatranI would like to comment on a few points discussed in the article on dabigatran (Medication Forum, April/May 2011). CABG adds little to ischemic heart failure treatment Sensitive troponin assay improves MI detection Value of adiposity measures such as BMI questioned Managing heart failure on the front lines of care Family physicians are key players in helping patients to follow treatment plans and avoid hospitalization Radial artery access is rad for PCI Yes, alcohol can be good for you Stillbirth and repeat miscarriages raise heart attack risk The pressure’s on to treat resistant hypertension Causes of this common problem in primary care may include overlooked comorbidities or unrelated medications First Previous 76 77 78 79 80 Next Last
